NCT06380205

A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females

A Phase 1, Open-Label Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Incyte Corporation · Industry
• Sex: Female
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the drug interaction between povorcitinib and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females.

Conditions

• Healthy Participants

Interventions

Type	Name	Description
DRUG	Povorcitinib	Povorcitinib will be administered at protocol defined dose.
DRUG	Levonorgestrel/Ethinyl estradiol	Levonorgestrel/Ethinyl estradiol will be administered at protocol defined dose.

Timeline

• Start date: 2024-05-07
• Primary completion: 2024-06-07
• Completion: 2024-06-07
• First posted: 2024-04-23
• Last updated: 2024-07-03

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study